Browse Good Future’s latest public updates, technical insights, and video content from one place.
40 items
A newly published MDPI paper showed that CSV+ CTCs measured on Good Future's automated negative selection platform may support metastatic-risk stratification and recurrence monitoring in breast cancer.
Good Future concluded four days of discussions and demonstrations at the 2025 Healthcare+ Expo Taiwan, welcoming healthcare professionals and visitors from Taiwan and Southeast Asia.
Good Future and Inventec Appliances presented Chiline CATCH, Family Pal, and TTSmart at Medical Fair Asia 2024 in Singapore.
Good Future and Wellspring are developing a partnership in Malaysia focused on professional training, market development, and healthcare collaboration.
A media report examined how Good Future and Inventec Appliances are developing automated CTC testing and expanding healthcare partnerships in Thailand and Malaysia.
5 items
See why CSV+ CTCs stood out in this study and what the results suggest for metastatic-risk stratification and recurrence monitoring.
Learn how CTCs enter the bloodstream and why CTC testing is being studied as an adjunct for cancer-risk assessment and follow-up.
Learn how red blood cell removal, white blood cell identification, and magnetic separation can enrich candidate CTCs without relying on a single tumor marker.
Follow the Good Future workflow from specimen collection and cell enrichment to immunofluorescence imaging and report delivery.
7 videos
An Era TV feature introduces Good Future's CTC testing workflow through interviews with healthcare and industry professionals.
A short animated introduction to circulating tumor cells and the basic steps used in CTC testing.
Dr. Tseng Chih-Jen discusses liquid biopsy, CTC testing, and how blood-based information may complement established clinical examinations.